Latham BioPharm Group Awarded Grant to Develop a Global Health Cost Model Platform

BALTIMORE, June 21, 2023 /PRNewswire/ — Latham BioPharm Group (LBG), part of Sia Partners, has been awarded a grant by the Bill & Melinda Gates Foundation to develop an easy-to-use, web-based modeling tool for use in determining the cost of goods of pharmaceutical APIs. The tool will provide a cost-effective means for a wide variety … Read more